Clinical Trial

Impact of Early Antibiotics on Non-Traumatic Out of Hospital Cardiac Arrest (OHCA)

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 3, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Specific Aim : The specific aim is to conduct a randomized prospective clinical trial to determine whether no antibiotics in OHCA patients in the ED with very low likelihood of infection is non-inferior to early antibiotic treatment. Hypothesis a: 28-day all-cause mortality will be non-inferior in OHCA patients with very low likelihood of infection who do not receive antibiotic therapy compared with those who receive early antibiotic therapy Hypothesis b: There will be no difference in subsequent incidence of proven infections in the no antibiotics vs, early antibiotics groups Hypothesis c: There will be no difference in the length of ICU stay and overall hospital stay in the early antibiotics vs. no antibiotics groups
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-06-21; most recent amendment 2025-04-01.
Status change: Active, Not Recruiting → Recruiting 2023-11-16
Trial Details
NCT Number NCT05914779
Lead Sponsor Hamad Medical Corporation
Conditions Infection, Bacterial, Out-Of-Hospital Cardiac Arrest
Enrollment 1,000 participants
Start Date 2023-03-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-03